The very fact they have positioned the company for the growth pending that FDA approval.
Employed 2 fulltime consultants to onsell. Distibutor setup in U.S with shelves already stocked all these things are costly but they also show how forward thinking this company has. Got to spend it to make it and some will be eating their words come next quarter sales.
- Forums
- ASX - By Stock
- OCC
- Ann: Quarterly Activity Report & Appendix 4C
OCC
orthocell limited
Add to My Watchlist
3.21%
!
$1.21

Ann: Quarterly Activity Report & Appendix 4C, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.21 |
Change
-0.040(3.21%) |
Mkt cap ! $293.2M |
Open | High | Low | Value | Volume |
$1.22 | $1.24 | $1.20 | $737.4K | 608.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 17546 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 1.205 |
14 | 110398 | 1.200 |
2 | 10794 | 1.195 |
9 | 49980 | 1.190 |
2 | 1687 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.215 | 17546 | 1 |
1.225 | 3282 | 1 |
1.230 | 16282 | 3 |
1.235 | 5000 | 1 |
1.240 | 34786 | 2 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |